{"id":2756,"date":"2021-10-07T09:18:00","date_gmt":"2021-10-07T07:18:00","guid":{"rendered":"https:\/\/eae.gr\/uncategorized\/thromvotiki-mikroaggeiopatheia\/"},"modified":"2024-07-27T00:22:28","modified_gmt":"2024-07-26T22:22:28","slug":"thromvotiki-mikroaggeiopatheia","status":"publish","type":"post","link":"https:\/\/eae.gr\/en\/active-clinical-studies-en\/thromvotiki-mikroaggeiopatheia\/","title":{"rendered":"\u0398\u03a1\u039f\u039c\u0392\u03a9\u03a4\u0399\u039a\u0397 \u039c\u0399\u039a\u03a1\u039f\u0391\u0393\u0393\u0395\u0399\u039f\u03a0\u0391\u0398\u0395\u0399\u0391"},"content":{"rendered":"<p><strong>APPELHUS &#8211; CLNP023F12301\/ Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy (APPELHUS)<\/strong><\/p>\n<p>\u039c\u03af\u03b1 \u03c0\u03bf\u03bb\u03c5\u03ba\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03ae \u03b1\u03bd\u03bf\u03b9\u03c7\u03c4\u03bf\u03cd \u03c3\u03c7\u03b5\u03b4\u03b9\u03b1\u03c3\u03bc\u03bf\u03cd \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03b1\u03be\u03b9\u03bf\u03bb\u03cc\u03b3\u03b7\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03b1\u03c3\u03c6\u03ac\u03bb\u03b5\u03b9\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03b5\u03c3\u03bc\u03b1\u03c4\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c4\u03bf\u03c5 \u03b1\u03c0\u03cc \u03c4\u03bf\u03c5 \u03c3\u03c4\u03cc\u03bc\u03b1\u03c4\u03bf\u03c2 \u03c7\u03bf\u03c1\u03b7\u03b3\u03bf\u03cd\u03bc\u03b5\u03bd\u03bf\u03c5 LNP023 \u03c3\u03b5 \u03b5\u03bd\u03ae\u03bb\u03b9\u03ba\u03b5\u03c2 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 \u03ac\u03c4\u03c5\u03c0\u03bf \u03bf\u03c5\u03c1\u03b1\u03b9\u03bc\u03b9\u03ba\u03cc \u03b1\u03b9\u03bc\u03bf\u03bb\u03c5\u03c4\u03b9\u03ba\u03cc \u03c3\u03cd\u03bd\u03b4\u03c1\u03bf\u03bc\u03bf \u03c0\u03bf\u03c5 \u03b4\u03b5\u03bd \u03ad\u03c7\u03bf\u03c5\u03bd \u03c0\u03c1\u03bf\u03b7\u03b3\u03bf\u03cd\u03bc\u03b5\u03bd\u03b1 \u03bb\u03ac\u03b2\u03b5\u03b9 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1 \u03bc\u03b5 \u03b1\u03bd\u03b1\u03c3\u03c4\u03bf\u03bb\u03ad\u03b1 \u03c3\u03c5\u03bc\u03c0\u03bb\u03b7\u03c1\u03ce\u03bc\u03b1\u03c4\u03bf\u03c2<\/p>\n<p><span style=\"color: #ff0000;\">Estimated Study Completion Date January 6, 2026<\/span><\/p>\n<p><span style=\"color: #0000ff;\"><em>ClinicalTrials.gov Identifier: NCT04889430<\/em><\/span><\/p>\n<p><span style=\"color: #0000ff;\"><em>2020-005186-13 ( EudraCT Number )<\/em><\/span><\/p>\n<p><em>\u039a\u0395\u039d\u03a4\u03a1\u0391 \u03a0\u039f\u03a5 \u03a3\u03a5\u039c\u039c\u0395\u03a4\u0395\u03a7\u039f\u03a5\u039d:<\/em><\/p>\n<p><em>. \u0391\u0399\u039c\u0391\u03a4\u039f\u039b\u039f\u0393\u0399\u039a\u0397 \u039a\u039b\u0399\u039d\u0399\u039a\u0397-\u039c\u039c\u039c\u039f, \u0393\u0395\u039d\u0399\u039a\u039f \u039d\u039f\u03a3\u039f\u039a\u039f\u039c\u0395\u0399\u039f \u0398\u0395\u03a3\u03a3\u0391\u039b\u039f\u039d\u0399\u039a\u0397\u03a3 &#8220;\u0393. \u03a0\u0391\u03a0\u0391\u039d\u0399\u039a\u039f\u039b\u0391\u039f\u03a5&#8221;, \u03a5\u03c0\u03b5\u03c5\u03b8. \u0399. \u03a3\u03b1\u03ba\u03b5\u03bb\u03bb\u03ac\u03c1\u03b7, \u0398\u0395\u03a3\u03a3\u0391\u039b\u039f\u039d\u0399\u039a\u0397<\/em><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>APPELHUS &#8211; CLNP023F12301\/ Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy (APPELHUS) \u039c\u03af\u03b1 \u03c0\u03bf\u03bb\u03c5\u03ba\u03b5\u03bd\u03c4\u03c1\u03b9\u03ba\u03ae \u03b1\u03bd\u03bf\u03b9\u03c7\u03c4\u03bf\u03cd<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[178],"tags":[],"class_list":["post-2756","post","type-post","status-publish","format-standard","hentry","category-active-clinical-studies-en"],"_links":{"self":[{"href":"https:\/\/eae.gr\/en\/wp-json\/wp\/v2\/posts\/2756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eae.gr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eae.gr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eae.gr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/eae.gr\/en\/wp-json\/wp\/v2\/comments?post=2756"}],"version-history":[{"count":1,"href":"https:\/\/eae.gr\/en\/wp-json\/wp\/v2\/posts\/2756\/revisions"}],"predecessor-version":[{"id":2760,"href":"https:\/\/eae.gr\/en\/wp-json\/wp\/v2\/posts\/2756\/revisions\/2760"}],"wp:attachment":[{"href":"https:\/\/eae.gr\/en\/wp-json\/wp\/v2\/media?parent=2756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eae.gr\/en\/wp-json\/wp\/v2\/categories?post=2756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eae.gr\/en\/wp-json\/wp\/v2\/tags?post=2756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}